Top Markets
#1 Siren Siren +30.60%
#2 OriginTrail OriginTrail +26.61%
#3 Waves Waves +12.47%
#4 Tutorial Tutorial +10.44%
#5 MarsCoin MarsCoin +9.18%
#6 Pons Pons +8.78%
#7 Concordium Concordium +6.10%
#8 PulseChain PulseChain +5.89%
#9 Fabric Protocol Fabric Protocol +5.35%
#10 COTI COTI +5.13%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Wuhan YZY Biopharma Co Ltd Wuhan YZY Biopharma Co Ltd

Wuhan YZY Biopharma Co Ltd

2496
Rank in Stocks #22213
Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the... Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the development of bispecific antibody-based treatments. Its therapeutic focus areas include various cancers, their associated complications, and age-related ophthalmic conditions. The company's extensive portfolio of drug candidates aims to address a wide range of diseases, such as malignant ascites, malignant pleural effusion, various solid tumors (including pancreatic cancer, hepatocellular carcinoma, other advanced solid tumors, and HER2-positive solid tumors), small cell lung cancer, and relapsed/refractory multiple myeloma. Additionally, they are advancing therapies for COVID-19 and several eye disorders like wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and other conditions characterized by abnormal blood vessel formation in the eye. The company, established in 2010, is headquartered in Wuhan, China.
Share Price
$0.46053443
Last synced: 2026-08-13
Market Cap
$92.44M
Change (1 day)
0.00%
Change (1 year)
-36.86%
Country
CN
Trade Wuhan YZY Biopharma Co Ltd (2496)

Category

Healthcare
Operating Margin for Wuhan YZY Biopharma Co Ltd (2496)
Operating Margin as of 2026 TTM: 0.00%
According to Wuhan YZY Biopharma Co Ltd latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Wuhan YZY Biopharma Co Ltd from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.